Legal Representation
Attorney
Tracy-Gene G. Durkin
USPTO Deadlines
Next Deadline
24 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 15, 2025
Extension Available
Until August 15, 2024
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 14, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 14, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 30, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 30, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 16, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 15, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 15, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 15, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 20, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 20, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 11, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 10, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 10, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 15, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 15, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 15, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 3, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 30, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer; pharmaceutical preparations, biological preparations, and cell- and gene-based therapy products to prevent and treat age-related cardiovascular disease, neurodegenerative disease, musculoskeletal disease, pulmonary disease, metabolic disease, diseases of the liver, macular degeneration and other ocular diseases, kidney disease, and cancer
Class 042
Pharmaceutical and biological drug research and development services; research and development of pharmaceutical and biotechnology fields, namely, cell- and gene-based therapy research and development services; providing information about medical and scientific research on aging and complex multigenic diseases; providing information about medical and scientific research, namely, providing information on pharmaceutical drug, biological drug, and cell- and gene-based therapy research and development; providing scientific information on computational biology, machine learning, and bioinformatics
Class 044
Providing medical information on aging and complex multigenic diseases
Classification
International Classes
005
042
044